Treating depression during COVID-19: Considerations for psychological and psychiatric treatment

Presented by Rachel Leonard, PhD, LP, and Christopher Lowden, MD

View slides from this presentation

Review behavioral activation theory and pharmacotherapy for depression, and gain an understanding of the benefits of a combined approach, in part one of this webinar series. Time will also be spent identifying necessary modifications for pharmacotherapy during COVID-19 and adaptations for behavioral activation, which are necessary when treatment is provided via telehealth.

 

Related resources

#
Treating anxious and depressed youth with ASD during COVID-19
In this webinar, learn about the unique challenges facing youth with autism…
Learn more
#
Treating co-occurring mental health and addiction during COVID-19: Cultural and community factors
Part two of this series will highlight important cultural considerations…
Learn more
#
Treating co-occurring mental health and addiction during COVID-19: Considerations for telehealth
In part one of this webinar series, learn about the factors that must be…
Learn more

Call 800-767-4411 or go to rogersbh.org to request a free screening.